Examination of visual evaluation and deficits in children treated for primary brain tumors

Takeaway

  • A referral for ophthalmologic examination is recommended for all children enrolled in clinical trials to treat brain tumors, as most patients (pts) with visual deficits do not report visual symptoms.

Why this matters

  • In most pediatric neuro-oncology clinical trials, visual impairment in children with brain tumors is not typically evaluated on enrollment or following treatment; no standard guidelines for referral for ophthalmologic evaluation exist.

  • Untreated visual impairment could have an impact on self-perception and quality of life.